Global Tasigna Market Growth 2020-2025

Publication Month: Nov 2020 | No. of Pages: 133 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

According to this study, over the next five years the Tasigna market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Tasigna business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Tasigna market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Tasigna, covering the supply chain analysis, impact assessment to the Tasigna market size growth rate in several scenarios, and the measures to be undertaken by Tasigna companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
50mg
200mg
Other

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drugs Store
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Tasigna consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Tasigna market by identifying its various subsegments.
Focuses on the key global Tasigna manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tasigna with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Tasigna submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tasigna Consumption 2015-2025
2.1.2 Tasigna Consumption CAGR by Region
2.2 Tasigna Segment by Type
2.2.1 50mg
2.2.2 200mg
2.2.3 Other
2.3 Tasigna Consumption by Type
2.3.1 Global Tasigna Consumption Market Share by Type (2015-2020)
2.3.2 Global Tasigna Revenue and Market Share by Type (2015-2020)
2.3.3 Global Tasigna Sale Price by Type (2015-2020)
2.4 Tasigna Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Tasigna Consumption by Application
2.5.1 Global Tasigna Consumption Market Share by Type (2015-2020)
2.5.2 Global Tasigna Value and Market Share by Type (2015-2020)
2.5.3 Global Tasigna Sale Price by Type (2015-2020)

3 Global Tasigna by Company
3.1 Global Tasigna Sales Market Share by Company
3.1.1 Global Tasigna Sales by Company (2018-2020)
3.1.2 Global Tasigna Sales Market Share by Company (2018-2020)
3.2 Global Tasigna Revenue Market Share by Company
3.2.1 Global Tasigna Revenue by Company (2018-2020)
3.2.2 Global Tasigna Revenue Market Share by Company (2018-2020)
3.3 Global Tasigna Sale Price by Company
3.4 Global Tasigna Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Tasigna Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Tasigna Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Tasigna by Regions
4.1 Tasigna by Regions
4.2 Americas Tasigna Consumption Growth
4.3 APAC Tasigna Consumption Growth
4.4 Europe Tasigna Consumption Growth
4.5 Middle East & Africa Tasigna Consumption Growth

5 Americas
5.1 Americas Tasigna Consumption by Countries
5.1.1 Americas Tasigna Consumption by Countries (2015-2020)
5.1.2 Americas Tasigna Value by Countries (2015-2020)
5.2 Americas Tasigna Consumption by Type
5.3 Americas Tasigna Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Tasigna Consumption by Regions
6.1.1 APAC Tasigna Consumption by Regions (2015-2020)
6.1.2 APAC Tasigna Value by Regions (2015-2020)
6.2 APAC Tasigna Consumption by Type
6.3 APAC Tasigna Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Tasigna by Countries
7.1.1 Europe Tasigna Consumption by Countries (2015-2020)
7.1.2 Europe Tasigna Value by Countries (2015-2020)
7.2 Europe Tasigna Consumption by Type
7.3 Europe Tasigna Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Tasigna by Countries
8.1.1 Middle East & Africa Tasigna Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Tasigna Value by Countries (2015-2020)
8.2 Middle East & Africa Tasigna Consumption by Type
8.3 Middle East & Africa Tasigna Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Tasigna Distributors
10.3 Tasigna Customer

11 Global Tasigna Market Forecast
11.1 Global Tasigna Consumption Forecast (2021-2025)
11.2 Global Tasigna Forecast by Regions
11.2.1 Global Tasigna Forecast by Regions (2021-2025)
11.2.2 Global Tasigna Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Tasigna Forecast by Type
11.8 Global Tasigna Forecast by Application

12 Key Players Analysis
12.1 Novartis
12.1.1 Company Information
12.1.2 Tasigna Product Offered
12.1.3 Novartis Tasigna Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Novartis Latest Developments
...

13 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Tasigna Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 50mg
Table 5. Major Players of 200mg
Table 6. Major Players of Other
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Tasigna Consumption Market Share by Type (2015-2020)
Table 9. Global Tasigna Revenue by Type (2015-2020) ($ million)
Table 10. Global Tasigna Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Tasigna Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Tasigna Consumption Market Share by Application (2015-2020)
Table 14. Global Tasigna Value by Application (2015-2020)
Table 15. Global Tasigna Value Market Share by Application (2015-2020)
Table 16. Global Tasigna Sale Price by Application (2015-2020)
Table 17. Global Tasigna Sales by Company (2017-2019) (MT)
Table 18. Global Tasigna Sales Market Share by Company (2017-2019)
Table 19. Global Tasigna Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Tasigna Revenue Market Share by Company (2017-2019)
Table 21. Global Tasigna Sale Price by Company (2017-2019)
Table 22. Global Tasigna Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Tasigna Products Offered
Table 24. Tasigna Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Tasigna Consumption by Regions 2015-2020 (MT)
Table 26. Global Tasigna Consumption Market Share by Regions 2015-2020
Table 27. Global Tasigna Value by Regions 2015-2020 ($ Millions)
Table 28. Global Tasigna Value Market Share by Regions 2015-2020
Table 29. Americas Tasigna Consumption by Countries (2015-2020) (MT)
Table 30. Americas Tasigna Consumption Market Share by Countries (2015-2020)
Table 31. Americas Tasigna Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Tasigna Value Market Share by Countries (2015-2020)
Table 33. Americas Tasigna Consumption by Type (2015-2020) (MT)
Table 34. Americas Tasigna Consumption Market Share by Type (2015-2020)
Table 35. Americas Tasigna Consumption by Application (2015-2020) (MT)
Table 36. Americas Tasigna Consumption Market Share by Application (2015-2020)
Table 37. APAC Tasigna Consumption by Regions (2015-2020) (MT)
Table 38. APAC Tasigna Consumption Market Share by Regions (2015-2020)
Table 39. APAC Tasigna Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Tasigna Value Market Share by Regions (2015-2020)
Table 41. APAC Tasigna Consumption by Type (2015-2020) (MT)
Table 42. APAC Tasigna Consumption Market Share by Type (2015-2020)
Table 43. APAC Tasigna Consumption by Application (2015-2020) (MT)
Table 44. APAC Tasigna Consumption Market Share by Application (2015-2020)
Table 45. Europe Tasigna Consumption by Countries (2015-2020) (MT)
Table 46. Europe Tasigna Consumption Market Share by Countries (2015-2020)
Table 47. Europe Tasigna Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Tasigna Value Market Share by Countries (2015-2020)
Table 49. Europe Tasigna Consumption by Type (2015-2020) (MT)
Table 50. Europe Tasigna Consumption Market Share by Type (2015-2020)
Table 51. Europe Tasigna Consumption by Application (2015-2020) (MT)
Table 52. Europe Tasigna Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Tasigna Consumption by Countries (2015-2020) (MT)
Table 54. Middle East & Africa Tasigna Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Tasigna Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Tasigna Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Tasigna Consumption by Type (2015-2020) (MT)
Table 58. Middle East & Africa Tasigna Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Tasigna Consumption by Application (2015-2020) (MT)
Table 60. Middle East & Africa Tasigna Consumption Market Share by Application (2015-2020)
Table 61. Tasigna Distributors List
Table 62. Tasigna Customer List
Table 63. Global Tasigna Consumption Forecast by Countries (2021-2025) (MT)
Table 64. Global Tasigna Consumption Market Forecast by Regions
Table 65. Global Tasigna Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Tasigna Value Market Share Forecast by Regions
Table 67. Global Tasigna Consumption Forecast by Type (2021-2025) (MT)
Table 68. Global Tasigna Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Tasigna Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Tasigna Value Market Share Forecast by Type (2021-2025)
Table 71. Global Tasigna Consumption Forecast by Application (2021-2025) (MT)
Table 72. Global Tasigna Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Tasigna Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Tasigna Value Market Share Forecast by Application (2021-2025)
Table 75. Novartis Product Offered
Table 76. Novartis Tasigna Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 77. Novartis Main Business
Table 78. Novartis Latest Developments
Table 79. Novartis Basic Information, Company Total Revenue (in $ million), Tasigna Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Tasigna
Figure 2. Tasigna Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Tasigna Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Tasigna Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 50mg
Figure 7. Product Picture of 200mg
Figure 8. Product Picture of Other
Figure 9. Global Tasigna Consumption Market Share by Type (2015-2020)
Figure 10. Global Tasigna Value Market Share by Type (2015-2020)
Figure 11. Tasigna Consumed in Hospital
Figure 12. Global Tasigna Market: Hospital (2015-2020) (MT)
Figure 13. Global Tasigna Market: Hospital (2015-2020) ($ Millions)
Figure 14. Tasigna Consumed in Drugs Store
Figure 15. Global Tasigna Market: Drugs Store (2015-2020) (MT)
Figure 16. Global Tasigna Market: Drugs Store (2015-2020) ($ Millions)
Figure 17. Tasigna Consumed in Other
Figure 18. Global Tasigna Market: Other (2015-2020) (MT)
Figure 19. Global Tasigna Market: Other (2015-2020) ($ Millions)
Figure 20. Global Tasigna Consumption Market Share by Application (2015-2020)
Figure 21. Global Tasigna Value Market Share by Application (2015-2020)
Figure 22. Global Tasigna Sales Market Share by Company in 2017
Figure 23. Global Tasigna Sales Market Share by Company in 2019
Figure 24. Global Tasigna Revenue Market Share by Company in 2017
Figure 25. Global Tasigna Revenue Market Share by Company in 2019
Figure 26. Global Tasigna Sale Price by Company in 2019
Figure 27. Global Tasigna Consumption Market Share by Regions 2015-2020
Figure 28. Global Tasigna Value Market Share by Regions 2015-2020
Figure 29. Americas Tasigna Consumption 2015-2020 (MT)
Figure 30. Americas Tasigna Value 2015-2020 ($ Millions)
Figure 31. APAC Tasigna Consumption 2015-2020 (MT)
Figure 32. APAC Tasigna Value 2015-2020 ($ Millions)
Figure 33. Europe Tasigna Consumption 2015-2020 (MT)
Figure 34. Europe Tasigna Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Tasigna Consumption 2015-2020 (MT)
Figure 36. Middle East & Africa Tasigna Value 2015-2020 ($ Millions)
Figure 37. Americas Tasigna Consumption Market Share by Countries in 2019
Figure 38. Americas Tasigna Value Market Share by Countries in 2019
Figure 39. Americas Tasigna Consumption Market Share by Type in 2019
Figure 40. Americas Tasigna Consumption Market Share by Application in 2019
Figure 41. United States Tasigna Consumption Growth 2015-2020 (MT)
Figure 42. United States Tasigna Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Tasigna Consumption Growth 2015-2020 (MT)
Figure 44. Canada Tasigna Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Tasigna Consumption Growth 2015-2020 (MT)
Figure 46. Mexico Tasigna Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Tasigna Consumption Market Share by Countries in 2019
Figure 48. APAC Tasigna Value Market Share by Regions in 2019
Figure 49. APAC Tasigna Consumption Market Share by Type in 2019
Figure 50. APAC Tasigna Consumption Market Share by Application in 2019
Figure 51. China Tasigna Consumption Growth 2015-2020 (MT)
Figure 52. China Tasigna Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Tasigna Consumption Growth 2015-2020 (MT)
Figure 54. Japan Tasigna Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Tasigna Consumption Growth 2015-2020 (MT)
Figure 56. Korea Tasigna Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Tasigna Consumption Growth 2015-2020 (MT)
Figure 58. Southeast Asia Tasigna Value Growth 2015-2020 ($ Millions)
Figure 59. India Tasigna Consumption Growth 2015-2020 (MT)
Figure 60. India Tasigna Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Tasigna Consumption Growth 2015-2020 (MT)
Figure 62. Australia Tasigna Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Tasigna Consumption Market Share by Countries in 2019
Figure 64. Europe Tasigna Value Market Share by Countries in 2019
Figure 65. Europe Tasigna Consumption Market Share by Type in 2019
Figure 66. Europe Tasigna Consumption Market Share by Application in 2019
Figure 67. Germany Tasigna Consumption Growth 2015-2020 (MT)
Figure 68. Germany Tasigna Value Growth 2015-2020 ($ Millions)
Figure 69. France Tasigna Consumption Growth 2015-2020 (MT)
Figure 70. France Tasigna Value Growth 2015-2020 ($ Millions)
Figure 71. UK Tasigna Consumption Growth 2015-2020 (MT)
Figure 72. UK Tasigna Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Tasigna Consumption Growth 2015-2020 (MT)
Figure 74. Italy Tasigna Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Tasigna Consumption Growth 2015-2020 (MT)
Figure 76. Russia Tasigna Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Tasigna Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Tasigna Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Tasigna Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Tasigna Consumption Market Share by Application in 2019
Figure 81. Egypt Tasigna Consumption Growth 2015-2020 (MT)
Figure 82. Egypt Tasigna Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Tasigna Consumption Growth 2015-2020 (MT)
Figure 84. South Africa Tasigna Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Tasigna Consumption Growth 2015-2020 (MT)
Figure 86. Israel Tasigna Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Tasigna Consumption Growth 2015-2020 (MT)
Figure 88. Turkey Tasigna Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Tasigna Consumption Growth 2015-2020 (MT)
Figure 90. GCC Countries Tasigna Value Growth 2015-2020 ($ Millions)
Figure 91. Global Tasigna Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 92. Global Tasigna Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Tasigna Consumption 2021-2025 (MT)
Figure 94. Americas Tasigna Value 2021-2025 ($ Millions)
Figure 95. APAC Tasigna Consumption 2021-2025 (MT)
Figure 96. APAC Tasigna Value 2021-2025 ($ Millions)
Figure 97. Europe Tasigna Consumption 2021-2025 (MT)
Figure 98. Europe Tasigna Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Tasigna Consumption 2021-2025 (MT)
Figure 100. Middle East & Africa Tasigna Value 2021-2025 ($ Millions)
Figure 101. United States Tasigna Consumption 2021-2025 (MT)
Figure 102. United States Tasigna Value 2021-2025 ($ Millions)
Figure 103. Canada Tasigna Consumption 2021-2025 (MT)
Figure 104. Canada Tasigna Value 2021-2025 ($ Millions)
Figure 105. Mexico Tasigna Consumption 2021-2025 (MT)
Figure 106. Mexico Tasigna Value 2021-2025 ($ Millions)
Figure 107. Brazil Tasigna Consumption 2021-2025 (MT)
Figure 108. Brazil Tasigna Value 2021-2025 ($ Millions)
Figure 109. China Tasigna Consumption 2021-2025 (MT)
Figure 110. China Tasigna Value 2021-2025 ($ Millions)
Figure 111. Japan Tasigna Consumption 2021-2025 (MT)
Figure 112. Japan Tasigna Value 2021-2025 ($ Millions)
Figure 113. Korea Tasigna Consumption 2021-2025 (MT)
Figure 114. Korea Tasigna Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Tasigna Consumption 2021-2025 (MT)
Figure 116. Southeast Asia Tasigna Value 2021-2025 ($ Millions)
Figure 117. India Tasigna Consumption 2021-2025 (MT)
Figure 118. India Tasigna Value 2021-2025 ($ Millions)
Figure 119. Australia Tasigna Consumption 2021-2025 (MT)
Figure 120. Australia Tasigna Value 2021-2025 ($ Millions)
Figure 121. Germany Tasigna Consumption 2021-2025 (MT)
Figure 122. Germany Tasigna Value 2021-2025 ($ Millions)
Figure 123. France Tasigna Consumption 2021-2025 (MT)
Figure 124. France Tasigna Value 2021-2025 ($ Millions)
Figure 125. UK Tasigna Consumption 2021-2025 (MT)
Figure 126. UK Tasigna Value 2021-2025 ($ Millions)
Figure 127. Italy Tasigna Consumption 2021-2025 (MT)
Figure 128. Italy Tasigna Value 2021-2025 ($ Millions)
Figure 129. Russia Tasigna Consumption 2021-2025 (MT)
Figure 130. Russia Tasigna Value 2021-2025 ($ Millions)
Figure 131. Spain Tasigna Consumption 2021-2025 (MT)
Figure 132. Spain Tasigna Value 2021-2025 ($ Millions)
Figure 133. Egypt Tasigna Consumption 2021-2025 (MT)
Figure 134. Egypt Tasigna Value 2021-2025 ($ Millions)
Figure 135. South Africa Tasigna Consumption 2021-2025 (MT)
Figure 136. South Africa Tasigna Value 2021-2025 ($ Millions)
Figure 137. Israel Tasigna Consumption 2021-2025 (MT)
Figure 138. Israel Tasigna Value 2021-2025 ($ Millions)
Figure 139. Turkey Tasigna Consumption 2021-2025 (MT)
Figure 140. Turkey Tasigna Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Tasigna Consumption 2021-2025 (MT)
Figure 142. GCC Countries Tasigna Value 2021-2025 ($ Millions)
Figure 143. Novartis Tasigna Market Share (2018-2020)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets